FDA Drug Application (021806) for VANDAZOLE by TEVA PHARMS

Back to FDA Applications sponsored by TEVA PHARMS

Application Number021806
Product Number001
FormGEL;VAGINAL
Dosage0.75%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code BX Drug products for which the data are insufficient to determine therapeutic equivalence
Reference Drug
Drug NameVANDAZOLE
Active IngredientMETRONIDAZOLE

Active IngredientCount
List of drugs with Active Ingredient METRONIDAZOLE19


Back to FDA Applications sponsored by TEVA PHARMS